GHK-Cu (Copper Peptide): Skin, Wound Healing & Anti-Aging Research
What Is GHK-Cu? GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first identified in human plasma by Dr. Loren Pickart in 1973.
What Is GHK-Cu? GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first identified in human plasma by Dr. Loren Pickart in 1973.
Introduction to Growth Hormone Secretagogues Growth hormone (GH) secretion from the anterior pituitary is regulated by two primary opposing signals: growth hormone-releasing hormone (GHRH), which stimulates GH release, and somatostatin, which inhibits it.
A research overview of TB-500, the synthetic fragment of thymosin beta-4: mechanism of action, study findings, and regulatory status. For laboratory use.
Semax and NA Semax Amidate share the same core structure but differ in potency, stability, and duration. This guide explains the chemistry and research implications of each modification.
Keloid scars result from overactive collagen production. Research into GHK-Cu and BPC-157 suggests these peptides may influence the biological pathways driving keloid formation.
Post-surgical adhesions are fibrous scar bands that form after surgery. BPC-157, TB-500, and GHK-Cu are studied for anti-inflammatory and matrix remodeling properties relevant to adhesion prevention.
GHK-Cu targets structural skin aging through collagen synthesis. SNAP-8 inhibits expression lines at the neuromuscular level. Both are studied for anti-aging applications but work completely differently.
Acetic acid water plays a critical role in reconstituting specific research peptides. This guide covers which peptides require it, the science behind why, reconstitution protocols, and storage.
Bacteriostatic water is one of the most fundamental supplies in peptide research. This guide covers composition, reconstitution protocols, concentration calculations, storage, and peptide compatibility.
Clinical trial participants on tirzepatide most commonly reported nausea, dramatic appetite reduction, early satiety, and GI side effects during dose escalation. Here’s the published data.